Business Development Approach


DURECT has several proprietary drug delivery platforms including oral, injectable, transdermal and implantable that can be the basis of novel and proprietary dosage forms.

Researchers in lab





At DURECT, we understand the complexity and challenges you face in bringing new drugs to market. We also understand that risk is inherent throughout the development and approval process. And we believe we can help you to manage and minimize this risk through unique partnering relationships. In addition, our delivery platforms may help extend the proprietary positions of your drug franchises and enable new claims with novel dosage forms.

At DURECT, we offer a broad range of innovative drug delivery systems that are an essential element to any new controlled-release drug product. We offer sustained release technology platforms that provide delivery of your product from days to months based on your therapeutic and business needs. Many, but not all, of these technology options can be found here on our website. Our dedicated team of scientists and formulators offer additional expertise to custom-tailor drug delivery to your needs, whether parenteral, oral, transdermal, local or topical. It is this experience and expertise that accelerate your product development timelines, reduce your risk and increase your chances for success.

Contact:
Michael Arenberg
Senior Vice President, Corporate and Business Development
Phone: 408.346.1052
Fax: 408.777.3577
mike.arenberg@durect.com



 
 © 2000-2014 DURECT Corporation
Last updated: December 16, 2014
Search     Contact     Site Index     Legal Notice     Privacy Policy